Informações:
Falhas:
ID
20083
Descrição
An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: AVA100468, Sponsor: GSK
Palavras-chave
Versões (2)
- 31/01/2017 31/01/2017 -
- 06/02/2017 06/02/2017 -
Transferido a
6 de fevereiro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Study Conclusion GSK-AVA100468 NCT00381238
Study Conclusion GSK-AVA100468 NCT00381238
- StudyEvent: ODM
Similar models
Study Conclusion GSK-AVA100468 NCT00381238
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item
Did the subject become pregnant during the study? (Check that responses provided correspond with the sex of the subject) If `Yes`, complete Pregnancy Notification
integer
C0032961 (UMLS CUI [1])
Code List
Did the subject become pregnant during the study? (Check that responses provided correspond with the sex of the subject) If `Yes`, complete Pregnancy Notification
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (not of childbearing potential or male) (3)
End Date
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1])
Withdrawal
Item
Was the subject withdrawn from the study?
boolean
C2349954 (UMLS CUI [1])
Item
What was the primary reason for withdrawal?
integer
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (5)
CL Item
Non-compliance (6)
CL Item
Other (7)
Withdrawal Other
Item
What was the primary reason for withdrawal? If other, specify:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,2])